3,000
Participants
Start Date
July 3, 2023
Primary Completion Date
January 1, 2025
Study Completion Date
November 30, 2025
75 mg acetylsalicylic acid
75 mg acetylsalicylic acid (C9H8O4, CAS number 50-78-2) daily, Oral
1.5g Metformin
up to 1.5 g metformin (C4H11N5, CAS number 657-24-9) daily, Oral Dose increases from 0.5g to 1.0g to 1.5g
150 mg acetylsalicylic acid
150 mg acetylsalicylic acid (C9H8O4, CAS number 50-78-2) daily, Oral
Placebo of acetylsalicylic acid and Metformin
Pills with shape, color and smell same with acetylsalicylic acid and metformin, daily, oral
RECRUITING
Peking University First Hospital, Beijing
WITHDRAWN
Guangzhou Women and Children's Medical Center, Guangzhou
NOT_YET_RECRUITING
The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou
RECRUITING
Obstetrics and Gynecology Hospital of Fudan University, Shanghai
RECRUITING
Shanghai First Maternity and Infant Hospital, Shanghai
RECRUITING
West China Second University Hospital, Sichuan University, Chengdu
Obstetrics & Gynecology Hospital of Fudan University
OTHER
Shanghai First Maternity and Infant Hospital
OTHER
West China Second University Hospital
OTHER
Peking University First Hospital
OTHER
Chinese University of Hong Kong
OTHER